Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 159

1.

Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.

Leon L, Gomez A, Vadillo C, Pato E, Rodriguez-Rodriguez L, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2017 Jun 6. [Epub ahead of print]

PMID:
28598787
2.

Impact of body mass index on ovarian cancer survival varies by stage.

Bandera EV, Lee VS, Qin B, Rodriguez-Rodriguez L, Powell CB, Kushi LH.

Br J Cancer. 2017 Jun 6. doi: 10.1038/bjc.2017.162. [Epub ahead of print]

PMID:
28588323
3.

BRAF fusion as a novel mechanism of acquired resistance to vemurafenib in BRAF V600E mutant melanoma.

Kulkarni A, Al-Hraishawi H, Simhadri S, Hirshfield KM, Chen S, Pine SR, Jeyamohan C, Sokol L, Ali SM, Teo ML, White E, Rodriguez-Rodriguez L, Mehnert JM, Ganesan S.

Clin Cancer Res. 2017 May 24. pii: clincanres.0758.2016. doi: 10.1158/1078-0432.CCR-16-0758. [Epub ahead of print]

PMID:
28539463
4.

Vision-related Quality of Life in Patients with Non-infectious Uveitis: A Cross-sectional Study.

Arriola-Villalobos P, Abásolo L, García-Feijoo J, Fernández-Gutiérrez B, Méndez-Fernández R, Pato E, Díaz-Valle D, Rodriguez-Rodriguez L.

Ocul Immunol Inflamm. 2017 Mar 21:1-9. doi: 10.1080/09273948.2017.1285034. [Epub ahead of print]

PMID:
28323495
5.

Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice.

Leon L, Rodriguez-Rodriguez L, Freites D, Arietti L, Morado I, Vadillo C, Lamas JR, Fernandez B, Jover JA, Abasolo L.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):165-170. Epub 2017 Jan 23.

PMID:
28134073
6.

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

López-Mejías R, Corrales A, Vicente E, Robustillo-Villarino M, González-Juanatey C, Llorca J, Genre F, Remuzgo-Martínez S, Dierssen-Sotos T, Miranda-Filloy JA, Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Ferraz-Amaro I, Gómez-Vaquero C, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Ocejo-Vinyals JG, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2017 Jan 6;7:40303. doi: 10.1038/srep40303.

7.

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment.

Rojas V, Hirshfield KM, Ganesan S, Rodriguez-Rodriguez L.

Int J Mol Sci. 2016 Dec 15;17(12). pii: E2113. Review.

8.

Precision targeted therapy of ovarian cancer.

Sapiezynski J, Taratula O, Rodriguez-Rodriguez L, Minko T.

J Control Release. 2016 Dec 10;243:250-268. doi: 10.1016/j.jconrel.2016.10.014. Epub 2016 Oct 14. Review.

9.

Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival.

Bandera EV, Lee VS, Rodriguez-Rodriguez L, Powell CB, Kushi LH.

Clin Cancer Res. 2016 Dec 1;22(23):5909-5914. Epub 2016 Aug 12.

PMID:
27521449
10.

Rab1 in cell signaling, cancer and other diseases.

Yang XZ, Li XX, Zhang YJ, Rodriguez-Rodriguez L, Xiang MQ, Wang HY, Zheng XF.

Oncogene. 2016 Nov 3;35(44):5699-5704. doi: 10.1038/onc.2016.81. Epub 2016 Apr 4. Review.

11.

Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice.

Leon L, Rodriguez-Rodriguez L, Rosales Z, Gomez A, Lamas JR, Pato E, Jover JA, Abasolo L.

Scand J Rheumatol. 2016 Nov;45(6):456-460. Epub 2016 Apr 26.

PMID:
27115843
12.

JC virus reactivation in patients with autoimmune rheumatic diseases treated with rituximab.

Domínguez-Mozo MI, Toledano-Martínez E, Rodríguez-Rodríguez L, García-Montojo M, Alvarez-Lafuente R, Fernández-Gutiérrez B.

Scand J Rheumatol. 2016 Nov;45(6):507-511. Epub 2016 Apr 11.

PMID:
27063911
13.

Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers.

López-Mejías R, Castañeda S, González-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, Remuzgo-Martínez S, Rodriguez-Rodriguez L, Blanco R, Llorca J, Martín J, González-Gay MA.

Autoimmun Rev. 2016 Nov;15(11):1013-1030. doi: 10.1016/j.autrev.2016.07.026. Epub 2016 Aug 1. Review.

14.

Treatment in rheumatoid arthritis and mortality risk in clinical practice: the role of biologic agents.

Rodriguez-Rodriguez L, Leon L, Ivorra-Cortes J, Gómez A, Lamas JR, Pato E, Jover JÁ, Abásolo L.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1026-1032. Epub 2016 Oct 7.

PMID:
27749239
15.

Influence of patient personality in the treatment of rheumatoid arthritis.

Leon L, Redondo M, Garcia-Vadillo A, Perez-Nieto MA, Rodriguez-Rodriguez L, Jover JA, Gonzalez-Alvaro I, Abasolo L.

Rheumatol Int. 2016 Nov;36(11):1549-1555. Epub 2016 Sep 10.

PMID:
27614619
16.

Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.

Hirshfield KM, Tolkunov D, Zhong H, Ali SM, Stein MN, Murphy S, Vig H, Vazquez A, Glod J, Moss RA, Belyi V, Chan CS, Chen S, Goodell L, Foran D, Yelensky R, Palma NA, Sun JX, Miller VA, Stephens PJ, Ross JS, Kaufman H, Poplin E, Mehnert J, Tan AR, Bertino JR, Aisner J, DiPaola RS, Rodriguez-Rodriguez L, Ganesan S.

Oncologist. 2016 Aug 26. pii: theoncologist.2016-0049. [Epub ahead of print]

17.

Genetic Analysis with the Immunochip Platform in Behçet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci.

Ortiz-Fernández L, Carmona FD, Montes-Cano MA, García-Lozano JR, Conde-Jaldón M, Ortego-Centeno N, Castillo MJ, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Juliá MR, Solans R, Blanco R, Barnosi-Marín AC, Gómez de la Torre R, Fanlo P, Rodríguez-Carballeira M, Rodríguez-Rodríguez L, Camps T, Castañeda S, Alegre-Sancho JJ, Martín J, González-Escribano MF.

PLoS One. 2016 Aug 22;11(8):e0161305. doi: 10.1371/journal.pone.0161305. eCollection 2016.

18.

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

López-Mejías R, Genre F, Remuzgo-Martínez S, González-Juanatey C, Robustillo-Villarino M, Llorca J, Corrales A, Vicente E, Miranda-Filloy JA, Magro C, Tejera-Segura B, Ramírez Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Mínguez Sánchez MD, Gómez-Vaquero C, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2016 Aug 18;6:31979. doi: 10.1038/srep31979.

19.

Precision Medicine: Implications for Science and Practice.

Ganesan S, Rodriguez-Rodriguez L, DiPaola RS.

J Am Coll Surg. 2016 Sep;223(3):433-439.e1. doi: 10.1016/j.jamcollsurg.2016.05.020. Epub 2016 Jun 16. No abstract available.

PMID:
27321387
20.

Immunosuppressive Drug Discontinuation in Noninfectious Uveitis From Real-Life Clinical Practice: A Survival Analysis.

Abásolo L, Rosales Z, Díaz-Valle D, Gómez-Gómez A, Peña-Blanco RC, Prieto-García Á, Benítez-Del-Castillo JM, Pato E, García-Feijoo J, Fernández-Gutiérrez B, Rodriguez-Rodriguez L.

Am J Ophthalmol. 2016 Sep;169:1-8. doi: 10.1016/j.ajo.2016.06.007. Epub 2016 Jun 11.

PMID:
27296486

Supplemental Content

Loading ...
Support Center